Page 1595 - Small Animal Internal Medicine, 6th Edition

Index 1567

Myocardial diseases Myositis (Continued) Natriuretic peptides Nervous system (Continued)
in cats masticatory muscle, 451, 1091f, description of, 13 lesion localization and, 1037–1043,
arrhythmogenic right ventricular protozoal, 1177–1178 Nausea, chemotherapy-related, 1280 spinal cord. see Spinal cord
1038b
dilated cardiomyopathy and, 144
1174–1175, 1175f, 1252
VetBooks.ir corticosteroid-associated heart Myotomy, cricopharyngeal, 452 Nebulization Neural lymphoma, 1297
cardiomyopathy, 171
failure, 171–172
Myotonia, 1180–1181
Neuroanatomic regions, 1038b
airway hydration using, 342
description of, 158
oxygen supplementation use of, 383
Myxedema coma, 772
hypertrophic cardiomyopathy. see Myxedema, 769–770 Nebulizers, 342, 342f Neuroaxonal dystrophy, 1080
Neurodegenerative disorders, 1116
Hypertrophic cardiomyopathy, Myxomatous degeneration, 119 Neck pain, 1053, 1053f–1054f, 1055b, Neuroendocrine reflex, 974–975
in cats 1117–1119, 1118b Neuroepithelioma, 1145
myocarditis, 172 N Necrotizing leukoencephalitis, 1122 Neurogenic dysphagia, 391
dilated cardiomyopathy, 169–171 N-acetyl-β-D-glucosaminidase (NAG), Necrotizing meningoencephalomyelitis, Neurogenic keratitis, 1160–1161
in dogs, 141–157 660 1121–1122 Neurologic disorders, 1029–1031, 1031f
arrhythmogenic right ventricular N-acetylcysteine, idiopathic pulmonary Necrotizing splenitis, 1412–1413, 1412t Neurologic examination, 1063
cardiomyopathy, 148–150 fibrosis treated with, 351 Nematodes, 1532–1536, 1533t–1535t lesion localization, 1037–1062
dilated cardiomyopathy. see Dilated Nadolol, 94t Ollulanus tricuspis, 465 screening
cardiomyopathy, in dogs Nanophyetus salmincola, 413 Physaloptera rara, 464–465 ataxia, 1045–1046, 1046f, 1046b
doxorubicin-induced cardiotoxicity, Nares Nemex. see Pyrantel; Pyrantel pamoate components of, 1043b
150 rhinoscopy of, 251f Neo-Mercazole. see Carbimazole consciousness, disorders of, 1043t
free radicals, 151 stenotic, 279, 279f Neomycin, 515t–517t, 1437t–1438t description of, 1043–1061
hypertrophic cardiomyopathy. see Nasal aspergillosis Neonates gait, 1045–1046
Hypertrophic cardiomyopathy, description of, 242, 242f exam, anomalies apparent at, head tilt, 1043–1044, 1044f
in dogs diagnosis of, 256 1013–1033, 1013f, 1015f–1016f, mental state, 1043
ischemic myocardial disease, radiographic signs of, 249b, 250f 1021f muscle size, 1047
151–152 Nasal biopsy fading, 1021–1022, 1021f–1022f muscle tone, 1047
L-carnitine deficiency, 151 complications of, 255 orphans’ special needs, 1022–1023, pain, 1052f, 1053–1054
secondary causes of, 150–152 hemorrhage caused by, 255 1023f paralysis, 1045, 1045t
tachycardia-induced indications for, 253–255 pediatric systemic abnormalities, paresis, 1045, 1045t
cardiomyopathy, 152 nasal flush, 254 1023–1033 postural reactions, 1046–1047,
ischemic, in dogs, 151–152 nasal swabs, 254 resuscitation of, 1007–1013, 1048f
restrictive cardiomyopathy, 168–169, pinch biopsy, 254–255, 254f 1008f–1012f, 1008b–1010b, 1014t, posture, 1043–1045, 1044f
169f techniques for, 253–255 1016t, 1018t–1020t sensory evaluation, 1051–1052,
Myocardial dysfunction, sepsis-induced, turbinectomy, 255 Neonatology, 1007–1034 1052f
155 Nasal capillariasis, 263–264 Neoplasia, 613–615. see also Cancer spinal reflexes. see Spinal reflexes
Myocardial failure, 58–59. see also Heart Nasal catheters, 383–384, 384f canine thyroid. see Canine thyroid urinary tract function, 1054
failure Nasal cavity, 247–256 neoplasia systemic abnormalities, search for, 1063
Myocardial hypertrophy, 105 Nasal cultures, 255–256 in cats, 576–577 Neurologic lesions
in cats, 158 Nasal discharge intracranial, 1081–1082, 1082f diagnostic approach to, 1061, 1061b
as compensatory response, 167 after nasal aspergillosis treatment, 260 laryngeal, 281 animal history, 1061
description of, 55–56 classification of, 240–241 lung disease onset and progression, 1061
hyperthyroidism and, 162 computed tomography evaluations, bronchoalveolar lavage findings, 352f localization of, 1061
Myocardial ischemia, 159 244 clinical features of, 352 Neuromuscular junction (NMJ)
Myocardial strain, 32 diagnostic approach to, 241–244, 242f, diagnosis of, 352–353, 352f description of, 1041–1042, 1157
Myocardial thickening, 160–162 243b metastatic, 1289–1290 disorders of, 1164b, 1168–1172
Myocarditis differential diagnosis of, 241b pleural effusion caused by, 364, 366f acute fulminating myasthenia
bacterial, 153 etiology of, 240–241 prognosis for, 353 gravis, 1167t, 1170
in cats, 172 mucopurulent, 240–241, 241b, 1444 treatment of, 353 botulism, 1167t, 1169
clinical findings of, 154–155 physical examination of, 241 prostatic, 1003, 1003f myasthenia gravis, 1169–1172,
diagnosis of, 154–155 serous, 241b spinal cord, 1142 1171f, 1171b
in dogs, 153–155 serous or mucopurulent, 257 clinical features of, 1145 tick paralysis, 1167t, 1169
drug-related, 155 Nasal disease, clinical manifestations of, description of, 1145–1147, 1145f Neuromuscular system
infective, 153–154 240–246 diagnosis of, 1145–1146 diagnostic tests of, 1063–1073
Lyme, 153 Nasal flush, 254 treatment of, 1146–1147 biochemical profile, 1063
lymphocytic, 153 Nasal foreign bodies testicular, 996–997, 996f–997f brainstem auditory evoked
noninfective, 154–155 description of, 240 Neoplasm(s), 1322–1337. see also Cancer response, 1072
parvoviral, 153 radiographic signs of, 249b esophageal, 460, 460f cerebrospinal fluid analysis. see
protozoal, 153–154 Nasal imaging gastric, 471–472 Cerebrospinal fluid
traumatic, 155 computed tomography, 250, 250f oral cavity computed tomography, 1066, 1067f
treatment of, 155 frontal sinus exploration, 252 in cats, 449 electrodiagnostic testing, 1071–1072
viral, 153, 172 indications for, 247 in dogs, 447–449, 448t electroencephalography, 1072
Myoclonus, 1181–1183 magnetic resonance imaging, 250, Neoplastic effusion, 375–376 electromyography, 1071–1072
Myocyte hypertrophy, 55 250f Neoplastic lymphocytosis, 1319 electroretinography, 1072
Myopathies radiography, 247–248, 248f–250f, Neoplastic pericardial effusions, 182 immunology, 1064
acquired metabolic, 1178–1179 249b Neorickettsia helminthoeca, 1481 laboratory studies, 1063–1064
canine idiopathic polymyositis, 1176 rhinoscopy, 250–252, 251f–252f, 253b Neospora caninum, 965–966, 1127, 1127f, magnetic resonance imaging,
centronuclear, 1179–1180, 1180f Nasal lymphoma, 265 1430, 1440t, 1520, 1521f 1066–1067, 1067t, 1068f–1069f
dermatomyositis, 1177, 1177f Nasal mites, 253f, 263 Neosporosis, 154, 965–966, 1118t, microbiology, 1064
extraocular myositis, 1175–1176, 1175f Nasal mycoses, 260–263 1127–1128, 1127f, 1520–1521 muscle biopsy, 1073
feline idiopathic polymyositis, aspergillosis. see Aspergillosis, nasal Neostigmine methylsulfate, 1185t–1186t, myelography, 1064–1065,
1176–1177 cryptococcosis, 260 1251t, 1255t–1256t 1065f–1066f
glucocorticoid excess, 1178 Nasal neoplasia, 249b Nephrectomy, 652 nerve biopsy, 1073
hypokalemic polymyopathy, Nasal polyps, 264 Nephrogenic diabetes insipidus, nerve conduction velocities, 1072
1178–1179, 1178f Nasal swabs, 254, 259f 654t–655t, 742, 742b radiographs, 1064
hypothyroidism, 1178 Nasal tumors, 265–266 Nephrotic syndrome serology, 1064
inflammatory, 1174–1178 Nasoesophageal tubes definition of, 675 spinal radiographs, 1064
inherited, 1179–1181 feeding uses of, 435 hypercoagulable state of, 684 lesions of, 1042b
masticatory muscle myositis, 451, placement of, 567f, 567b Nephrotoxicant, 686–687 muscle, 1042
1091f, 1174–1175, 1175f Nasopharyngeal lymphoma, 1296 Nephrotoxicity, chemotherapy-related, neuromuscular junction, 1041–1042
metabolic, 1178–1179, 1181 Nasopharyngeal polyps 1284 peripheral nerves, 1041
muscular dystrophy, 1179 feline, 264, 264f Nerve biopsy, 1073 Neuronal abiotrophies, 1153
myotonia, 1180–1181 peripheral vestibular disease caused Nerve conduction velocities, 1072 Neurontin. see Gabapentin
Myositis by, 1114 Nervous system Neuroophthalmologic evaluation,
atrophic, 451 radiographic signs of, 249f, 249b brain. see Brain 1084–1086
dermatomyositis, 1177, 1177f Nasopharynx diagnostic tests for, 1063–1073 dazzle reflex, 1085–1086
extraocular, 1175–1176, 1175f caudal, 251–252, 251f imaging, 1064–1067 eyeball position and movement
immune-mediated, 1252–1253, 1253b rhinoscopy of, 251 routine, 1064 disorders, 1086